News Details

Restoring Cellular Power Outages: A New Drug Candidate to Treat Mitochondrial Disease

A small biotech company is aiming to recharge tired cells, giving mitochondrial disease patients new hope of a disease-specific treatment.


“We focus on patients, going after disease with high unmet needs, like primary mitochondrial myopathies,” Niall O’Donnell, Ph.D., President, CEO and Director of Reneo Pharmaceuticals, told BioSpace.


Source: Reneo Pharmaceuticals, Inc.